$105.55 -1.26 (%) Johnson & Johnson - NYSE

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. AbbVie Hep-C Drug Gets Nod

    IBD | Dec. 19, 2014 | 18:47PM EST
  2. NASDAQ Dividend Achievers: Deere & Company

    GuruFocus | Dec. 19, 2014 | 14:50PM EST
  3. Is Johnson & Johnson Still A Worthy Buy?

    GuruFocus | Dec. 18, 2014 | 11:22AM EST
  4. Analysts See No Sweeter Deal For Volcano

    Benzinga | Dec. 17, 2014 | 15:34PM EST
  5. Why I Sold American Realty Capital Properties

    GuruFocus | Dec. 17, 2014 | 09:13AM EST
  6. Boston Scientific Lost the First Place in Innovation

    GuruFocus | Dec. 11, 2014 | 14:41PM EST
  7. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  8. Dividends vs. Stock Buybacks

    GuruFocus | Dec. 9, 2014 | 12:07PM EST
  9. J&J's Janssen Reports IMBRUVICA 'Shows Sustained Progression-Free Survival in Patients with High-Risk Chronic Lymphocytic Leukemia with Genetic Mutation'

    Benzinga | Dec. 9, 2014 | 07:39AM EST
  10. Top Global Stocks: Jazz, Actavis In IBD's World List

    IBD | Dec. 8, 2014 | 18:31PM EST
  11. New ETF For Environmentalists

    Benzinga | Dec. 5, 2014 | 12:36PM EST
  12. Stocks Hold Small Gains; Taser Hits New High

    IBD | Dec. 5, 2014 | 11:51AM EST
  13. Johnson & Johnson

    IBD | Dec. 3, 2014 | 18:40PM EST
  14. Markets Inch Higher Following Encouraging Beige Book Commentary

    Benzinga | Dec. 3, 2014 | 17:11PM EST
  15. Report: Johnson & Johnson May Put Splenda On Block

    Benzinga | Dec. 3, 2014 | 11:21AM EST
  16. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD | Dec. 2, 2014 | 12:23PM EST
  17. Top 4 Stocks In The Drug Manufacturers-Major Industry With The Highest Operating Margin

    Benzinga | Dec. 2, 2014 | 04:38AM EST
  18. U.S. Stocks Attractive As Euro-Area Economy Slides

    GuruFocus | Nov. 26, 2014 | 12:27PM EST
  19. Consolidated Edison Has Increased Dividends for 40 Years

    GuruFocus | Nov. 25, 2014 | 10:53AM EST
  20. Walmart Still Rules The Retail Roost

    GuruFocus | Nov. 21, 2014 | 13:05PM EST
  21. Riding The Bull Market With These 2 Momentum ETFs

    Benzinga | Nov. 20, 2014 | 15:10PM EST
  22. Inflation Low? Not If You’re Investing For Long Haul

    YCharts | Nov. 20, 2014 | 09:59AM EST
  23. Mallinckrodt tops, no outlook

    IBD | Nov. 19, 2014 | 19:01PM EST
  24. Making Money With Charles Payne: 11/19/14

    FoxBusiness | Nov. 19, 2014 | 18:00PM EST
  25. Mallinckrodt Q4 Earnings Beat Views, But Outlook Hazy

    IBD | Nov. 19, 2014 | 17:35PM EST
  26. Mallinckrodt Earnings Beat But No New Guidance

    IBD | Nov. 19, 2014 | 11:42AM EST
  27. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  28. Guru Ken Fisher's Top Five Quarterly Stocks

    GuruFocus | Nov. 16, 2014 | 23:17PM EST
  29. ADHD drug hits FDA trouble

    IBD | Nov. 13, 2014 | 18:37PM EST
  30. Mallinckrodt ADHD Drug Hits FDA Trouble; Stock Drops

    IBD | Nov. 13, 2014 | 11:09AM EST
  31. What Johnson & Johnson's 'Chart Watchers' Need To Know

    Benzinga | Nov. 12, 2014 | 12:28PM EST
  32. Jim Cramer Weighs In On Johnson & Johnson And Toyota Motor

    Benzinga | Nov. 10, 2014 | 21:09PM EST
  33. Merck Down On Hepatitis C Data; Gilead Rises

    IBD | Nov. 10, 2014 | 11:14AM EST
  34. #PreMarket Primer: Monday, November 10: Nuclear Talks Enter Second Day

    Benzinga | Nov. 10, 2014 | 07:54AM EST
  35. Which Mega-Caps Aren't Paying Taxes?

    Benzinga | Nov. 5, 2014 | 09:04AM EST
  36. Dividend Growth Stocks With A Defined-Benefit Pension

    GuruFocus | Nov. 4, 2014 | 11:26AM EST
  37. Johnson & Johnson Fairly Valued - I Will Bet on It

    GuruFocus | Oct. 30, 2014 | 12:26PM EST
  38. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  39. Video: Facebook, Gilead Post Earnings After The Close

    IBD | Oct. 28, 2014 | 14:00PM EST
  40. Receptos Soars After Lead Drug Racks Up Another Win

    IBD | Oct. 28, 2014 | 11:46AM EST
  41. Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble

    IBD | Oct. 27, 2014 | 15:38PM EST
  42. Procter & Gamble Co Shares Lower Following Management Change

    Benzinga | Oct. 23, 2014 | 13:42PM EST
  43. 3M the Cash Generation Machine in the Industrials Segment

    GuruFocus | Oct. 23, 2014 | 12:53PM EST
  44. Ebola Test To Begin In Jan.

    IBD | Oct. 22, 2014 | 18:53PM EST
  45. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  46. Major Indexes End Win Streak; Super Micro Surges

    IBD | Oct. 22, 2014 | 16:24PM EST
  47. Worried? Picks Of Mr. Cautious, 80% In Stocks

    YCharts | Oct. 22, 2014 | 15:51PM EST
  48. Stocks Erase Modest Gains; Apple Flirts With Breakout

    IBD | Oct. 22, 2014 | 15:06PM EST
  49. Dividend Aristocrats In Focus Part 24: Consolidated Edison

    GuruFocus | Oct. 22, 2014 | 14:43PM EST
  50. #PreMarket Primer: Wednesday, October 22: Johnson & Johnson Develops Ebola Vaccine

    Benzinga | Oct. 22, 2014 | 08:13AM EST
Trading Center